drugset
drugset / Trial / NCT00597051

Study of 3 Doses of ARD-0403 in Testosterone Deficient Men

NCT00597051 ↗

Phase 2 Completed 42 enrolled Ardana Bioscience Ltd
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine which dose, if any, results in testosterone levels within the normal range for men.

Timeline

Start
2005-10
Primary completion
2006-02
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject ARD-0403 Unknown — —

Indications

hypogonadism